Bernhard Nocht Institute for Tropical Medicine
The Bernhard Nocht Institute for Tropical Medicine (BNITM) is Germany’s largest institution for research, teaching, consulting and care in the field of tropical diseases and emerging infectious diseases. It is an independent, non-profit institution in the form of a foundation under public law as well as a national reference center for tropical infectious agents and WHO collaborating center for arboviruses and hemorrhagic fever viruses. The BNITM is a member of the Leibniz Association.
Federal Institute for Drugs and Medical Devices
The Federal Institute for Drugs and Medical Devices (BfArM) is an independent federal higher authority within the portfolio of the Federal Ministry of Health (BMG) with the responsibility to ensure the safety of medicinal products and patients in Germany. The BfArM main tasks include licensing, improving the safety of medicinal products, detecting and evaluating the risks of medical devices, and monitoring the legal traffic in narcotic drugs and precursors as well as research. Its legal basis is primarily the German Medicines Act (AMG), the Medical Devices Act (MPG), and Narcotic Drugs Act (BtMG).
German Central Committee against Tuberculosis
The German Central Committee for the Control of Tuberculosis (DZK), as a center of competence for tuberculosis, monitors the development of the disease at national as well as international level and investigates possible effects on Germany. Its members include the Robert Koch Institute and various other German professional societies and associations, as well as the majority of the German states. It is a non-profit association supported by the Federal Ministry of Health (BMG).
Research Centre Borstel – Leibniz Lung Centre
The Research Center Borstel (FZB) is the lung research center of the Leibniz Association. The focus is on chronic inflammatory lung diseases such as asthma, chronic obstructive pulmonary disease (COPD) and allergies, as well as tuberculosis and other infection-related inflammations of the lung.
The Friedrich-Loeffler-Institut (FLI) is the German Federal Research Institute for Animal Health and works and conducts research on classical farm animal sciences as well as on the prevention, diagnosis, control and epidemiology of viral and bacterial infections and zoonoses. It is an independent higher federal authority in the portfolio of the Federal Ministry of Food and Agriculture (BMEL) and its central tasks are defined in the Animal Health Act.
The Paul Ehrlich Institute (PEI) is the German federal institute for vaccines and biomedical drugs. It researches, tests and approves biomedical medicinal products for human use and immunological veterinary medicinal products. It also approves clinical trial procedures and records and evaluates possible side effects (pharmacovigilance). The PEI is a higher federal authority in the portfolio of the Federal Ministry of Health (BMG).
The Robert Koch Institute (RKI) is the national public health institute for Germany. The Institute is the central institution of the Federal Government in the field of biomedicine. Its core tasks include detecting, preventing and combating infectious diseases and improving the health situation in Germany. The RKI is part of the portfolio of the Federal Ministry of Health (BMG) and its central tasks are defined in the Infection Protection Act.